CHAPTER 44:22:02
REPORTING REQUIREMENTS
Section
44:22:02:01 Entities required to provide report.
44:22:02:02 Reportable conditions -- General criteria.
44:22:02:03 to 44:22:02:05 Repealed.
44:22:02:06 Reportable data elements for tumor registries.
44:22:02:07 Method of reporting for tumor registries.
44:22:02:08 Repealed.
44:22:02:09 Method of reporting for pathology laboratories.
44:22:02:09.01 Method of reporting for hospitals without tumor registries, physicians, physician assistants, nurse practitioners, nurse midwives, and free-standing radiology centers.
44:22:02:10 Reporting for other entities.
44:22:02:01. Entities required to provide report. Any
hospital, physician, physician assistant, nurse practitioner, or nurse midwife,
pathology laboratory, or free-standing radiology center that detects,
diagnoses, or treats a cancer case in South Dakota shall submit the information
needed on a cancer case to the department or its representative as required by
§§ 1-43-11 to 1-43-17, inclusive.
A federal tumor registry may
participate in the central cancer registry if the registry submits reports in
conformance with the same standards. Any other entity may voluntarily submit
any cancer case to the central cancer registry.
Source:
18 SDR 142, effective March 9, 1992; 29 SDR 21, effective August 27, 2002; 32
SDR 69, effective November 7, 2005.
General
Authority: SDCL 1-43-13.
Law
Implemented: SDCL 1-43-13, 1-43-15.
44:22:02:02. Reportable conditions -- General criteria.
The following conditions are reportable:
(1) Any neoplasm listed in
the International Classification of
Diseases for Oncology, Third Edition, 2000, with a behavior code of
"2", in situ, or "3", malignant, with the exception of:
(a) Carcinoma in situ of the cervix;
(b) Intraepithelial
neoplasia of the cervix (CIN) and prostate (PIN); and
(c) Basal or squamous
cell carcinoma of the non-mucoepidermoid sites of the skin (C44.0-C44.9):
(i) 8000-8005
Neoplasms malignant (NOS) (C44.0-C44.9);
(ii) 8000-8046
Epithelial carcinomas of the skin (C44.0-44.9);
(iii) 8050-8084
Papillary and squamous cell carcinomas of the skin (C44.0-C44.9); and
(iv) 8090-8110
Basal cell carcinomas of the skin (C44.0-C44.9);
(2) Any basal and squamous
cell carcinoma originating in mucoepidermoid sites: such as the lips
(C00.0-C00.9), anus (C21.0), vagina (C52.9), clitoris, labia, vulva
(C51.0-C51.9), scrotum (C63.2), or penis (C60.0-C60.9);
(3) Any vulvar (VIN III),
vaginal (VAIN III), and anal (AIN III) intraepithelial neoplasia;
(4) Any brain and central
nervous system tumor, benign or malignant; or
(5) Any tumor that is not
histologically confirmed but with any record that contains any of the following
words:
apparently |
favor |
probable |
typical
of |
appears
to |
favors |
suspect |
|
comparable
with |
malignant
appearing |
suspected |
|
compatible
with |
most
likely |
suspicious |
|
consistent
with |
presumed |
suspicious
for |
|
However, if the record contains the
word "suspicious" and there is no positive biopsy or physician's
clinical impression to support the cytology findings, the condition is not
reportable.
Source:
18 SDR 142, effective March 9, 1992; 29 SDR 21, effective August 27, 2002; 32
SDR 69, effective November 7, 2005.
General
Authority: SDCL 1-43-13.
Law
Implemented: SDCL 1-43-11, 1-43-13.
Reference:
International Classification of Diseases
for Oncology, Third Edition, 2000, World Health Organization. Copies may be
obtained from the World Health Organization Publications Center, USDA, 49 Sheridan Avenue, Albany, NY 12210. Cost: $54.
44:22:02:03. Reporting inconclusive diagnoses.Repealed.
Source: 18 SDR 142, effective March 9, 1992; repealed, 29 SDR 21, effective August 27, 2002.
44:22:02:04. Reporting of basal and squamous cell carcinomas of the skin.Repealed.
Source: 18 SDR 142, effective March 9, 1992; repealed, 29 SDR 21, effective August 27, 2002.
44:22:02:05. Standards for determining single and multiple
primary tumors. Repealed.
Source:
18 SDR 142, effective March 9, 1992; 29 SDR 21, effective August 27, 2002;
repealed, 32 SDR 69, effective November 7, 2005.
44:22:02:06. Reportable data elements for tumor registries.
A tumor registry shall report the minimal data elements in the required status
table in NAACCR Standards for Cancer
Registries, Volume II, for each case which meets the criteria established
in §§ 44:22:02:02 to 44:22:02:05, inclusive. These must be reported in the
designated NAACCR record layout in NAACCR's
Standards for Cancer Registries, Volume II.
Source:
18 SDR 142, effective March 9, 1992; 29 SDR 21, effective August 27, 2002; 32
SDR 69, effective November 7, 2005.
General
Authority: SDCL 1-43-13.
Law
Implemented: SDCL 1-43-13, 1-43-14.
Reference:
Standards for Cancer Registries,
Volume II, Data Standards and Data Dictionary, North Association of Central
Cancer Registries, NAACCR, 2121 W. White Oaks Drive, Suite C, Springfield, IL
62704. Free.
44:22:02:07. Method of reporting for tumor registries.
Each facility with a tumor registry shall provide to the department the data
elements described in § 44:22:02:06 for all cases which meet the reporting
criteria established in §§ 44:22:02:02 to 44:22:02:05, inclusive.
Abstracts must be completed within six months from the date of initial
diagnosis. Data must be transmitted to the central cancer registry at least on
a quarterly basis, by the following dates:
First
Quarter (January-March) |
September
30 of the same year |
Second
Quarter (April-June) |
December
31 of the same year |
Third
Quarter (July-September) |
March
31 of the next year |
Fourth
Quarter (October-December) |
June
30 of the next year |
Source:
18 SDR 142, effective March 9, 1992; 29 SDR 21, effective August 27, 2002; 32
SDR 69, effective November 7, 2005.
General
Authority: SDCL 1-43-13.
Law
Implemented: SDCL 1-43-13, 1-43-14.
44:22:02:08. Method of reporting for manual tumor registries.
Repealed.
Source:
18 SDR 142, effective March 9, 1992; 29 SDR 21, effective August 27, 2002;
repealed, 32 SDR 69, effective November 7, 2005.
44:22:02:09.01. Method of reporting for hospitals without tumor
registries, physicians, physician assistants, nurse practitioners, nurse
midwives, and free-standing radiology centers. Each provider shall complete
a form prescribed by the department if a cancer case is found by the department
through case finding mechanisms. The provider shall complete the form and
return it to the department within 30 days. If the hospitals, physician,
physician assistant, nurse practitioner, nurse midwife, or free-standing
radiology center is unable to complete the form, they can provide a copy of
that portion of the patient's medical record that contains the minimum
information necessary for the department to complete the form. The department
may request disease indices from hospitals without tumor registries,
physicians, physician assistants, nurse practitioners, nurse midwives, or
free-standing radiology centers to assist in case finding. The disease indices
shall be provided to the department within 30 days of the request.
Source:
32 SDR 69, effective November 7, 2005.
General
Authority: SDCL 1-43-13.
Law
Implemented: SDCL 1-43-11, 1-43-13.
44:22:02:10. Reporting for other entities. The central
cancer registry may develop an individual agreement with any entity. The
central cancer registry and administration of the entity shall mutually decide
how cancer cases will be made available to the central cancer registry.
Source:
29 SDR 21, effective August 27, 2002; 32 SDR 69, effective November 7, 2005.
General
Authority: SDCL 1-43-13.
Law
Implemented: SDCL 1-43-11, 1-43-13.